Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 4;24(1):436.
doi: 10.1186/s12890-024-03234-z.

Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review

Affiliations
Review

Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review

Fei-Xiang Ling et al. BMC Pulm Med. .

Abstract

Background: Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment methods are summarized to improve clinicians' understanding of the disease and to facilitate early diagnosis and treatment.

Case presentation: A 60-year-old male farmer with poorly controlled diabetes mellitus was admitted to hospital with a fever of unknown origin that had been present for 15 days and pulmonary aspergillosis complicated by Mucor spp.

Infection: Because multiple lobes were involved, the infection worsened despite surgical resection and antifungal therapy. Finally, we treated this patient with a bronchoscopic infusion of amphotericin B. After four courses of bronchoscopic amphotericin B infusion, we observed rapid clinical improvement and subsequent resolution of pulmonary infiltrates.

Conclusion: Our case highlights the use of bronchoscopy in the successful clinical treatment of invasive fungal diseases of the lung.

Keywords: Amphotericin B; Bronchoscopic treatment; Invasive fungal infections; Pulmonary aspergillosis; Pulmonary mucormycosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chest computed tomography (CT) (a, b) before starting treatment showing high-density shadows in both lungs and patchy, crescent-shaped low-density gas shadows in the lesions. (c) Chest CT taken 3.5 months later before starting bronchoscopic intramucosal liposomal amphotericin B treatment showing a slightly larger lesion in the right upper lobe of the lung. (d) Chest CT reexamination after 4 treatment courses showing obvious absorption of the lesion in the patient’s right lung
Fig. 2
Fig. 2
Hyphae of Mucor and Aspergillus observed on periodic acid-Schiff stain of lung biopsy samples (40×)

Similar articles

Cited by

References

    1. Rashbi KS, Ali T. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India. Access Microbiol. 2022;4(6):acmi360.10.1099/acmi.0.000360 - DOI - PMC - PubMed
    1. Garcia-Carnero LC, Mora-Montes HM. Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis[J]. J Fungi (Basel). 2022;8(5):445–5. - PMC - PubMed
    1. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395–401. 10.3201/eid1509.090334 - DOI - PMC - PubMed
    1. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–50. 10.1016/0003-4975(94)90243-7 - DOI - PubMed
    1. Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. 2016;146:w14281. - PubMed

MeSH terms

LinkOut - more resources